{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcdv1.1","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10102","date":"2024-07-08T18:11:56.403Z","role":"Publisher"},{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10102","date":"2024-04-11T16:00:00.000Z","role":"Approver"}],"curationReasons":[{"id":"cg:NewCuration"},{"id":"cg:ErrorClarification"}],"evidence":[{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:c0a6879e-55a9-497a-9482-9db073e7575c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c2744a88-7e7f-40fd-8fa3-859bcfba3ba1","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"GTEx expression data","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/23715323","type":"dc:BibliographicResource","dc:abstract":"Genome-wide association studies have identified thousands of loci for common diseases, but, for the majority of these, the mechanisms underlying disease susceptibility remain unknown. Most associated variants are not correlated with protein-coding changes, suggesting that polymorphisms in regulatory regions probably contribute to many disease phenotypes. Here we describe the Genotype-Tissue Expression (GTEx) project, which will establish a resource database and associated tissue bank for the scientific community to study the relationship between genetic variation and gene expression in human tissues.","dc:creator":"GTEx Consortium","dc:date":"2013","dc:title":"The Genotype-Tissue Expression (GTEx) project."},"rdfs:label":"GTEx bulk tissue expression"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"cggv:afc01224-52d7-49a6-a806-a7e85613014f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:e145fc2e-b4d8-481f-bd95-19f48e29a84c","type":"Finding","demonstrates":{"id":"obo:MI_0915"},"dc:description":"Co-IP experiment for myc-DYX1C1 and FLAG-DNAAF2 from HEK293 lysates\n","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/23872636","type":"dc:BibliographicResource","dc:abstract":"DYX1C1 has been associated with dyslexia and neuronal migration in the developing neocortex. Unexpectedly, we found that deleting exons 2-4 of Dyx1c1 in mice caused a phenotype resembling primary ciliary dyskinesia (PCD), a disorder characterized by chronic airway disease, laterality defects and male infertility. This phenotype was confirmed independently in mice with a Dyx1c1 c.T2A start-codon mutation recovered from an N-ethyl-N-nitrosourea (ENU) mutagenesis screen. Morpholinos targeting dyx1c1 in zebrafish also caused laterality and ciliary motility defects. In humans, we identified recessive loss-of-function DYX1C1 mutations in 12 individuals with PCD. Ultrastructural and immunofluorescence analyses of DYX1C1-mutant motile cilia in mice and humans showed disruptions of outer and inner dynein arms (ODAs and IDAs, respectively). DYX1C1 localizes to the cytoplasm of respiratory epithelial cells, its interactome is enriched for molecular chaperones, and it interacts with the cytoplasmic ODA and IDA assembly factor DNAAF2 (KTU). Thus, we propose that DYX1C1 is a newly identified dynein axonemal assembly factor (DNAAF4).","dc:creator":"Tarkar A","dc:date":"2013","dc:title":"DYX1C1 is required for axonemal dynein assembly and ciliary motility."},"rdfs:label":"DNAAF4 (DYX1C1) interacts with DNAAF2 "}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"cggv:1cf36dcb-8422-4bbc-98cd-7918ea93314b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:9646f79f-6a80-4b49-b38b-cf661519de97","type":"Finding","demonstrates":{"id":"cg:BiochemicalFunctionA"},"dc:description":"Similar assembly defects in patient cells","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/19944400","type":"dc:BibliographicResource","dc:abstract":"Genetic defects affecting motility of cilia and flagella cause chronic destructive airway disease, randomization of left-right body asymmetry, and, frequently, male infertility in primary ciliary dyskinesia (PCD). The most frequent defects involve outer and inner dynein arms (ODAs and IDAs) that are large multiprotein complexes responsible for cilia-beat generation and regulation, respectively. Here, we demonstrate that large genomic deletions, as well as point mutations involving LRRC50, are responsible for a distinct PCD variant that is characterized by a combined defect involving assembly of the ODAs and IDAs. Functional analyses showed that LRRC50 deficiency disrupts assembly of distally and proximally DNAH5- and DNAI2-containing ODA complexes, as well as DNALI1-containing IDA complexes, resulting in immotile cilia. On the basis of these findings, we assume that LRRC50 plays a role in assembly of distinct dynein-arm complexes.","dc:creator":"Loges NT","dc:date":"2009","dc:title":"Deletions and point mutations of LRRC50 cause primary ciliary dyskinesia due to dynein arm defects."},"rdfs:label":"DNAAF4 shares similar function to DNAAF1."}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:fdd3a670-8ba2-4d75-a846-9d01eca09a58","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:16597129-fba0-47f4-a4f2-f0b94842fc56","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Laterality defects\nImmotile cilia\nin common","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636","rdfs:label":"Zebrafish"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5,"dc:description":"Downscored due to failure to replicate key PCD phenotypes"},{"id":"cggv:86e81cdd-d90e-48c7-8af1-8bf5dbed5850","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:335e2251-cb07-4a6f-950f-35d181e742da","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Laterality defects \nImmotile cilia\nODA+IDA Defect (TEM)\nin common","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636","rdfs:label":"Mouse model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5},{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:fed521bb-61da-4bee-a91c-f60117d43730_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:fed521bb-61da-4bee-a91c-f60117d43730","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":43,"allele":{"id":"cggv:be14a1d6-e9e1-4c9e-adc8-4fc4e3d44543","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.390_393del (p.Val132Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7575055"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000789","obo:HP_0006510","obo:HP_0006532","obo:HP_0002643","obo:HP_0000403","obo:HP_0002205"],"previousTesting":true,"previousTestingDescription":"ODA+IDA defect identified using TEM, immotile cilia ","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:f06912a2-3877-4a27-b17b-3e3913f0bf23_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:be14a1d6-e9e1-4c9e-adc8-4fc4e3d44543"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},"rdfs:label":"Tarkar_2013_OP-556II1"},{"id":"cggv:f06912a2-3877-4a27-b17b-3e3913f0bf23","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:f06912a2-3877-4a27-b17b-3e3913f0bf23_variant_evidence_item"}],"strengthScore":0.5,"dc:description":"Downscore: homozygosity and limited sequencing"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:3dcecd4f-d47c-4865-84d8-a2424066e88e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:3dcecd4f-d47c-4865-84d8-a2424066e88e","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":{"id":"cggv:b2aa0c3d-24e0-421b-8939-679b600a09cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.583del (p.Ile195Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7575014"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0002205","obo:HP_0002020","obo:HP_0031245","obo:HP_0006510","obo:HP_0001696"],"previousTesting":true,"previousTestingDescription":"reduced ciliary beating, some immotile cilia\n","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:9086ded8-7b1f-4862-a3c8-fd6e6fa8ae49_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b2aa0c3d-24e0-421b-8939-679b600a09cd"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},"rdfs:label":"Tarkar_2013_ F-648II1"},{"id":"cggv:9086ded8-7b1f-4862-a3c8-fd6e6fa8ae49","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:9086ded8-7b1f-4862-a3c8-fd6e6fa8ae49_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: homozygosity and limited sequencing. Upscore: recurrence.\n"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:cd827905-d9d4-4adb-9c1b-8a6e392801a0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:cd827905-d9d4-4adb-9c1b-8a6e392801a0","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.55437099_55440647del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913184868"}},"detectionMethod":"CNV","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001328","obo:HP_0002257","obo:HP_0000252","obo:HP_0002643","obo:HP_0031245"],"previousTesting":true,"previousTestingDescription":"ODA+IDA defect identified using TEM, immotile cilia observed using HSVM\n","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:ec6c7fe5-4421-4d00-969c-cf30ffdb15e0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},"rdfs:label":"Tarkar_2013_ UCL-200 II1"},{"id":"cggv:ec6c7fe5-4421-4d00-969c-cf30ffdb15e0","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:ec6c7fe5-4421-4d00-969c-cf30ffdb15e0_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: homozygosity, consanguinity. Upscore: recurrence"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:0cda9942-009d-401a-86b8-1e41b041e1ab_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0cda9942-009d-401a-86b8-1e41b041e1ab","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"allele":{"id":"cggv:b2aa0c3d-24e0-421b-8939-679b600a09cd"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000403","obo:HP_0001696","obo:HP_0002205"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:3f41b0cd-bc35-4282-97dc-594af879a9ec_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b2aa0c3d-24e0-421b-8939-679b600a09cd"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},"rdfs:label":"Tarkar_2013_OP-359II1"},{"id":"cggv:3f41b0cd-bc35-4282-97dc-594af879a9ec","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:3f41b0cd-bc35-4282-97dc-594af879a9ec_variant_evidence_item"}],"strengthScore":0.25,"dc:description":"Downscore: homozygosity, limited sequencing, recurrence.\n"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:9d771be0-f78b-4bf9-be92-83f167312951_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:9d771be0-f78b-4bf9-be92-83f167312951","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":31,"allele":[{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},{"id":"cggv:f45d2e12-cf10-4a7e-90ed-b2cd52bbde31","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.325G>T (p.Glu109Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145167"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"Middle lobe parenchymal changes","phenotypes":["obo:HP_0002643","obo:HP_0000403","obo:HP_0002205","obo:HP_0000789"],"previousTestingDescription":"ODA + IDA defect identified using TEM","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"cggv:d3feb33c-81bc-4730-9f45-1661e318a71e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f45d2e12-cf10-4a7e-90ed-b2cd52bbde31"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},{"id":"cggv:40cc6416-9a24-4bd9-b4cb-0b3c0fdcfafd_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"}],"rdfs:label":"Tarkar_2013_UNC-1669"},{"id":"cggv:40cc6416-9a24-4bd9-b4cb-0b3c0fdcfafd","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:40cc6416-9a24-4bd9-b4cb-0b3c0fdcfafd_variant_evidence_item"}],"strengthScore":0.5,"dc:description":"Downscore: limited sequencing, recurrence"},{"id":"cggv:d3feb33c-81bc-4730-9f45-1661e318a71e","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:d3feb33c-81bc-4730-9f45-1661e318a71e_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: limited sequencing"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a4ad229b-0ed8-4e60-b5a0-60b997b8ec4c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a4ad229b-0ed8-4e60-b5a0-60b997b8ec4c","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000403","obo:HP_0000789","obo:HP_0002643","obo:HP_0002205","obo:HP_0001696","obo:HP_0002110"],"previousTestingDescription":"ODA+IDA defect, IC","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:cb44634f-3920-4ac0-9028-ef771fb814fa_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},"rdfs:label":"Tarkar_2013_ UNC-663"},{"id":"cggv:cb44634f-3920-4ac0-9028-ef771fb814fa","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:cb44634f-3920-4ac0-9028-ef771fb814fa_variant_evidence_item"}],"strengthScore":0.25,"dc:description":"Downscore: homozygosity, limited sequencing, recurrence"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e07a8b5c-9038-4a90-a91e-a37172070977_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e07a8b5c-9038-4a90-a91e-a37172070977","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":63,"allele":[{"id":"cggv:7ef5e1de-7bd2-4e66-9d23-85b269c63490","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.783+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392550540"}},{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"}],"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000403","obo:HP_0000789","obo:HP_0002205","obo:HP_0002110"],"previousTesting":true,"previousTestingDescription":"ODA+IDA defect identified using TEM","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"cggv:ff93e045-a445-49d2-97f5-550321de161a_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:7ef5e1de-7bd2-4e66-9d23-85b269c63490"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},{"id":"cggv:dc82908f-35ee-4ef9-a8d5-0c2c4d115ed4_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"}],"rdfs:label":"Tarkar_2013_UNC-159"},{"id":"cggv:dc82908f-35ee-4ef9-a8d5-0c2c4d115ed4","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:dc82908f-35ee-4ef9-a8d5-0c2c4d115ed4_variant_evidence_item"}],"strengthScore":0.5,"dc:description":"Downscore: sequencing and recurrence"},{"id":"cggv:ff93e045-a445-49d2-97f5-550321de161a","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:ff93e045-a445-49d2-97f5-550321de161a_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: sequencing"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:f0ff6046-493a-4dcb-a9b5-66d81f334fda_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f0ff6046-493a-4dcb-a9b5-66d81f334fda","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":37,"allele":{"id":"cggv:42dd2910-60de-47d3-890a-1ae46cfff1df","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.733C>T (p.Arg245Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7574974"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002110","obo:HP_0002650","obo:HP_0002257","obo:HP_0000789","obo:HP_0002205","obo:HP_0033036"],"previousTesting":true,"previousTestingDescription":"ODA+IDA defect identified using TEM, immotile cilia observed using HSVM\n","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:fea36095-2215-4319-909f-0772f5d52866_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:42dd2910-60de-47d3-890a-1ae46cfff1df"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/35903363","type":"dc:BibliographicResource","dc:creator":"Guo T","dc:date":"2022","dc:title":"Case Report: "}},"rdfs:label":"Guo_2022_P2"},{"id":"cggv:fea36095-2215-4319-909f-0772f5d52866","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:fea36095-2215-4319-909f-0772f5d52866_variant_evidence_item"}],"strengthScore":0.5,"dc:description":"Downscore due to homozygosity and consanguinity"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:82c0c9fd-f3a5-4e23-bc8b-95541a7ca744_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:82c0c9fd-f3a5-4e23-bc8b-95541a7ca744","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"cggv:7495b59c-eadc-4a8f-8122-8de8aa8dc806","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.988C>T (p.Arg330Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7574865"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002105","obo:HP_0002650","obo:HP_0031245","obo:HP_0002205","obo:HP_0002110","obo:HP_0002094"],"previousTesting":true,"previousTestingDescription":"ODA+IDA defect identified using TEM, immotile cilia observed using HSVM\n","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:6c498935-5ae4-41c1-941c-b0698c7c3438_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:7495b59c-eadc-4a8f-8122-8de8aa8dc806"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/35903363"},"rdfs:label":"Guo_2022_P1"},{"id":"cggv:6c498935-5ae4-41c1-941c-b0698c7c3438","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:6c498935-5ae4-41c1-941c-b0698c7c3438_variant_evidence_item"}],"strengthScore":0,"dc:description":"Downscore: homozygosity"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:d74ff678-d990-4c8b-b13a-df63181022e8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:d74ff678-d990-4c8b-b13a-df63181022e8","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":36,"allele":[{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},{"id":"cggv:82d9f7a5-b400-4b42-90ef-f370ce164668","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.252_253dup (p.Thr85ArgfsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695220841"}}],"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000403","obo:HP_0002643","obo:HP_0002205","obo:HP_0002110"],"previousTestingDescription":"ODA+IDA defect, immotile cilia ","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"cggv:8a142f74-82b8-4271-89d1-b6add9f47d9e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},{"id":"cggv:d1f22796-c9e2-4955-a9d7-208d8741d571_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:82d9f7a5-b400-4b42-90ef-f370ce164668"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"}],"rdfs:label":"Tarkar_2013_UNC-1171"},{"id":"cggv:d1f22796-c9e2-4955-a9d7-208d8741d571","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:d1f22796-c9e2-4955-a9d7-208d8741d571_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: sequencing"},{"id":"cggv:8a142f74-82b8-4271-89d1-b6add9f47d9e","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8a142f74-82b8-4271-89d1-b6add9f47d9e_variant_evidence_item"}],"strengthScore":0.5,"dc:description":"Downscore: sequencing and recurrence"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:7b2c3281-921d-43e0-9b04-4987083d6fc2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:7b2c3281-921d-43e0-9b04-4987083d6fc2","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":[{"id":"cggv:ec2e5e6c-43aa-4084-9464-ea71f0d5256d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.384C>A (p.Tyr128Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7575063"}},{"id":"cggv:016fa524-e122-4dfe-a2be-97c3d4e8a6ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.485G>A (p.Trp162Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392553730"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"learning disability ","phenotypes":["obo:HP_0000403","obo:HP_0001696","obo:HP_0100543","obo:HP_0006510"],"previousTesting":true,"previousTestingDescription":"TEM, immotile cilia","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"cggv:adf8f41d-d3c8-41c3-9077-c4b511ddb205_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:016fa524-e122-4dfe-a2be-97c3d4e8a6ae"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},{"id":"cggv:165c09ab-6fbb-4f37-bf90-dc33cf255777_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ec2e5e6c-43aa-4084-9464-ea71f0d5256d"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"}],"rdfs:label":"Tarkar_2013_OP-86II2"},{"id":"cggv:adf8f41d-d3c8-41c3-9077-c4b511ddb205","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:adf8f41d-d3c8-41c3-9077-c4b511ddb205_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: limited sequencing"},{"id":"cggv:165c09ab-6fbb-4f37-bf90-dc33cf255777","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:165c09ab-6fbb-4f37-bf90-dc33cf255777_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: limited sequencing"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:8e75a60d-4521-48be-a7c6-bb3fe961e82a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:8e75a60d-4521-48be-a7c6-bb3fe961e82a","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":[{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},{"id":"cggv:c5bfd100-abd2-4530-abd9-890570a32b01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_130810.4(DNAAF4):c.808C>T (p.Arg270Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145164"}}],"firstTestingMethod":"PCR","phenotypes":["obo:HP_0002643","obo:HP_0001651","obo:HP_0002205","obo:HP_0001748","obo:HP_0000403","obo:HP_0002110"],"previousTestingDescription":"ODA+IDA defect identified using TEM, immotile cilia","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"cggv:48361090-8acf-4397-af76-66fe54c442de_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:2dd6c6da-25f6-4f0e-a4c3-d3789861ea94"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"},{"id":"cggv:b29d4c17-0ae9-46b6-a77d-f59a652b9219_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c5bfd100-abd2-4530-abd9-890570a32b01"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23872636"}],"rdfs:label":"Tarkar_2013_UNC-1839"},{"id":"cggv:b29d4c17-0ae9-46b6-a77d-f59a652b9219","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:b29d4c17-0ae9-46b6-a77d-f59a652b9219_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscore: limited sequencing"},{"id":"cggv:48361090-8acf-4397-af76-66fe54c442de","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:48361090-8acf-4397-af76-66fe54c442de_variant_evidence_item"}],"strengthScore":0.5,"dc:description":"Downscore: limited sequencing and recurrence"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8675,"specifiedBy":"GeneValidityCriteria10","strengthScore":17,"subject":{"id":"cggv:caf488e2-066a-4a54-a5de-1536cbd0c121","type":"GeneValidityProposition","disease":"obo:MONDO_0014203","gene":"hgnc:21493","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","dc:description":"*DNAAF4* (also known as *DYX1C1*) was first reported in relation to autosomal recessive primary ciliary dyskinesia 25 (PCD25) in 2013 (Tarkar et al., PMID: 23872636). PCD25 is one of nearly 50 primary ciliary dyskinesias observed to be inherited in a monogenic fashion. Most PCD patients present with a chronic productive cough, recurrent respiratory infection, and chronic rhinosinusitis. Some patients also demonstrate situs inversus and neonatal respiratory distress (PMID: 33242470). Transmission electron microscopy (TEM) analysis of the respiratory cilia from all of the examined probands included in this curation demonstrated combined outer and inner dynein arm defects (PMIDs: 23872636, 35903363).\n\nVariants in *DNAAF4* have also been observed in association with susceptibility to dyslexia (PMID: 12954984). Multiple studies surrounding this association have yielded conflicting results (PMID:15520411, PMID: 15702132). Per criteria outlined by the ClinGen Lumping & Splitting Working Group, we found differences in molecular mechanism, inheritance pattern, and phenotypic variability relative to primary ciliary dyskinesia. Therefore, cases diagnosed with susceptibility to dyslexia or primary ciliary dyskinesia have been split into separate *DNAAF4* curations. This curation will focus only on primary ciliary dyskinesia 25 (OMIM:615482).\n\nThis curation includes eleven variants (eight nonsense, one frameshift, one consensus splice-site, and one large deletion) that have been reported in twelve probands in two publications (PMIDs: 23872636, 35903363). A deletion of 3549-bps encompassing exon 7 of *DNAAF4* was seen in six apparently unrelated probands (four heterozygotes and two homozygotes, PMID: 23872636)]. Of these six probands, one homozygote was from a highly consanguineous family of Irish descent, and one compound heterozygote was from a family of Australian ancestry. Three other compound heterozygotes and one homozygote were from families from North America. The 3549-bp deletion was observed in compound heterozygosity with four separate apparent loss-of-function variants (p.Glu109Ter, p.Arg270Ter, p.Thr85fs, and c.783+1G>T) in four independent families (PMID:23872636). The c.583delA (p.Ile195Ter) variant was also observed in 2 apparently unrelated homozygous probands of German descent (PMID: 23872636). More cases were available in the literature, but were not included in the curation as the maximum score for genetic evidence (12 pts) had been reached. The mechanism of pathogenicity appears to be loss-of-function. \n\nThis gene-disease relationship is also supported by experimental evidence including expression studies, functional assays, protein interaction evidence, and animal models (PMIDs: 23715323, 19944400, 23872636, 23872636, 23872636). GTEx expression data revealed high levels of *DNAAF4* in the brain, fallopian tube, lung, testis, and thyroid compared to other tissues in unaffected individuals, which is consistent with the PCD phenotype (PMID:23715323). Interaction evidence from a co-immunoprecipitation experiment demonstrated interaction between Dnaaf4 and Dnaaf2 (PMID:23872636). Since *DNAAF2* was definitively associated with PCD10 according to the Motile Ciliopathy GCEP, the interaction of the 2 proteins provides further evidence for the association between *DNAAF4* and PCD. Immunofluorescence in patient cells showed that both DNAAF4 and DNAAF1 play a role in the assembly and recruitment of other proteins (such as DNAH9, DNAH5, DNAI2, and DNALI1) to the cilia. Since the association between *DNAAF1* and PCD13 was previously classified as definitive by the Motile Ciliopathy GCEP, the similar molecular defects in cells from both *DNAAF1* and *DNAAF4* patients support the suspected role of *DNAAF4* variants in contributing to the PCD phenotype (PMIDs: 23872636, 19944400). A *Dnaaf4* knockout mouse model demonstrated laterality defects (59% situs inversus totalis) and combined outer and inner dynein arm defects, similarly to human patients with PCD25. The *Dnaaf4* KO mice also demonstrated immotile cilia in cerebral ventricles (PMID: 23872636). Finally, a zebrafish model created using morpholinos recapitulated the laterality defects (37.9% SIT, 25% heterotaxia), and immotile cilia in Kupffer's vesicles, which are consistent with phenotypes seen in PCD25 patients (PMID: 23872636).\n\nIn summary, *DNAAF4* is definitively associated with autosomal recessive primary ciliary dyskinesia 25. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Motile CIliopathy Gene Curation Expert Panel on the meeting date April 11th, 2024 (SOP Version 10).","dc:isVersionOf":{"id":"cggv:79950f5d-fd90-4765-9f8a-489c3f862fcd"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}